What is the recommended treatment for a urinary bladder stone measuring about 1.74 cm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment Recommendation for 1.74 cm Bladder Stone

For a bladder stone measuring 1.74 cm, transurethral cystolithotripsy (TUCL) is the recommended first-line treatment, offering the best balance of efficacy, safety, and recovery time.

Primary Treatment Approach

TUCL is the intervention of choice for bladder stones in this size range based on high-quality systematic review evidence 1. This endoscopic approach achieves stone-free rates equivalent to open surgery while providing significantly shorter catheterization time and hospital stay 1.

Why TUCL for This Stone Size

  • Optimal size range: At 1.74 cm, this stone falls within the ideal range for transurethral treatment. Research specifically comparing treatment modalities by stone size demonstrates that TUCL maintains shorter operative times for stones ≤2 cm (mean 34.1 ± 10.6 minutes) 2
  • Superior recovery profile: Compared to open cystolithotomy, TUCL results in significantly shorter catheter time, reduced postoperative hospital stay, and less hematocrit decrease across all stone size groups 2
  • Equivalent efficacy: Meta-analyses show no difference in stone-free rates between TUCL and open surgery, but with clear advantages in morbidity 1

Technical Considerations

Equipment Selection

Use a nephroscope rather than a standard cystoscope for TUCL when available. Meta-analysis of 4 RCTs demonstrates that nephroscope-assisted TUCL reduces procedure duration by approximately 23 minutes (p<0.00001) without compromising stone-free rates 1.

Lithotripsy Energy Source

  • Ho:YAG laser is the gold standard for stone fragmentation 3
  • Thulium fiber laser offers comparable efficacy and has been successfully used even for larger bladder stones 4
  • High-power settings reduce lasering time without proven clinical disadvantage 3

Alternative Treatment Options

When TUCL May Not Be Feasible

If transurethral access is not possible due to urethral stricture, anatomic abnormalities, or stone characteristics:

Percutaneous cystolithotripsy (PCCL) is the second-line option:

  • Four RCTs comparing TUCL versus PCCL found no difference in stone-free rates 1
  • However, PCCL results in longer hospital stay (mean difference 0.82 days, p<0.00001) and longer procedure duration (mean difference 9.83 minutes, p<0.00001) 1

Open Cystolithotomy

Reserved for cases where endoscopic approaches fail or are contraindicated:

  • Provides definitive stone removal but requires longer recovery
  • Significantly higher catheter time, postoperative stay, and hematocrit decrease 2

Shock Wave Lithotripsy (SWL)

Not recommended for bladder stones of this size:

  • One RCT demonstrated lower stone-free rates with SWL compared to TUCL (risk ratio 0.88, p=0.03) 1
  • Evidence quality is low, and SWL is generally less effective for bladder stones 1

Perioperative Management

Preoperative Requirements

  • Obtain urine microscopy and culture before stone treatment to exclude or treat urinary tract infection 3
  • Single-dose prophylactic antibiotic before ureteroscopy is sufficient 3
  • Tailor antibiotic choice to institutional or regional antimicrobial susceptibility patterns 3

Anticoagulation Considerations

  • TUCL is classified as a low-risk bleeding procedure 3
  • Patients on antithrombotic therapy should be referred to internal medicine for appropriate perioperative management 3

Stenting Decisions

  • Routine post-procedure stenting is unnecessary after uncomplicated TUCL 3
  • Consider stenting only if trauma, residual fragments, bleeding, perforation, UTI, or pregnancy are present 3
  • Alpha-blockers improve stent tolerability if stenting is required 3

Common Pitfalls to Avoid

  1. Don't attempt SWL: Despite its non-invasive nature, SWL has inferior stone-free rates for bladder stones and should not be offered 1

  2. Don't rush to open surgery: The evidence clearly favors endoscopic approaches for stones in this size range, with equivalent efficacy and superior recovery profiles 2, 1

  3. Don't use standard cystoscope if nephroscope available: The nephroscope significantly reduces operative time without compromising outcomes 1

  4. Don't forget infection screening: Untreated UTI is a contraindication to elective stone surgery and must be addressed preoperatively 3

Expected Outcomes

With TUCL for a 1.74 cm bladder stone, expect:

  • Complete stone clearance in a single procedure
  • Operative time approximately 30-40 minutes
  • Short catheterization period (typically 24-48 hours)
  • Hospital discharge within 1-2 days
  • Minimal blood loss and rapid return to normal activities

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.